Prof. Susana Marcos will present the latest breakthroughs in visual simulation at a key global event

London, United Kingdom – 2EyesVision continues to strengthen its global presence in ophthalmology innovation. On June 5, 2025, Prof. Susana Marcos, co-founder of 2EyesVision, will present SimVis Gekko2 at the AECOS Innovation Forum in London. This invitation marks the recognition of SimVis Gekko2 as a reference in surgical decision-making, offering real-time simulation of visual outcomes before cataract or presbyopia surgery. The event brings together top experts, surgeons, and innovators committed to advancing patient-centered care.

A key presence at AECOS London 2025

Prof. Susana Marcos will speak at the AECOS Innovation Forum in the Ballroom Foyer of the Park Plaza Riverbank Hotel. Her presentation will focus on how SimVis Gekko2 is redefining the preoperative experience by allowing patients to preview their vision with different IOLs in real time. This visual simulation empowers patients to actively participate in the decision-making process, moving beyond traditional explanations toward a data-driven, collaborative approach. By aligning expectations and outcomes, it fosters trust and leads to more confident, personalised surgical choices.

About AECOS: a global platform for innovation

AECOS (American-European Congress of Ophthalmic Surgery) is a leading society that unites surgeons, industry leaders, investors and entrepreneurs to advance anterior segment care. Established in 2011, it fosters innovation through collaboration, advocacy and education. As a 501(c)(6) nonprofit, AECOS has led efforts with the FDA and CMS on surgical guidance, while supporting pioneering technologies like corneal cross-linking and laser refractive cataract surgery.

“We’re excited to be part of AECOS and proud that SimVis Gekko2 continues to receive recognition among global leaders in ophthalmology,” says Prof. Susana Marcos, co-founder of 2EyesVision.

Participation in AECOS positions SimVis Gekko2 as one of the technologies shaping the next chapter of vision care. It reinforces 2EyesVision’s role as a bridge between cutting-edge science and real-world clinical application.

Are you looking to bring patient-centered innovation into your surgical practice?

Learn how SimVis Gekko2 can help elevate your decision-making and patient satisfaction

Are you interested in investing in SimVis Gekko2 and shaping the future of personalized eye care?

SimVis Gekko2 isn’t just transforming patient care — it’s a powerful growth opportunity. Ready to invest?